Tim Boreham reflects upon the August results season in Australia
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Macquarie counts the cost of capital for the ASX100; Jarden weighs the prospects for heavy emitters; Macquarie also examines where the downstream and upstream insurance emissions buck might stop; IEEFA spies rising credit-rating risk; and Morgan Stanley forecasts growing water capital expenditure for semiconductor and copper industries
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Lots of negative speculation preceded, but FY23 results for IDP Education were well received by brokers with technology initiatives suggesting ongoing growth
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
The Chartist has several Australian gold miners on watch ahead of a longer term bullish view
Tim Boreham shines a light on freshly listed Cleo Diagnostics, in search of an effective diagnostic tool for ovarian cancer
